Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy (Q73543421)
Jump to navigation
Jump to search
scientific article published on 01 June 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy |
scientific article published on 01 June 1997 |
Statements
Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy (English)
F M Brennan
K A Browne
P A Green
J M Jaspar
R N Maini